TRIM29 Antikörper (AA 1-200)
Kurzübersicht für TRIM29 Antikörper (AA 1-200) (ABIN7477605)
Target
Alle TRIM29 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-200
-
Immunogen
- Recombinant fragment (126 Amino acid residues between aa 1-200) of human TRIM29 protein
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC 1:100-1:200
-
Kommentare
-
Positive Control: Tonsil: A strong membranous and cytoplasmic TRIM29 immunostaining should be seen in squamous epithelial cells.
Negative Control: Tonsil: All non-epithelial cells must not show any TRIM29 immunostaining.
-
Protokoll
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
-
- TRIM29 (Tripartite Motif Containing 29 (TRIM29))
-
Andere Bezeichnung
- TRIM29
-
Hintergrund
- Ataxia telangiectasia group D complementing gene (ATDC), Tripartite motif-containing protein 29 (TRIM29),TRIM29 antibody validated for immunohistochemistry on 76 different Normal Tissues
-
UniProt
- Q14134
-
Pathways
- p53 Signalweg, Apoptose, DNA Reparatur, Inositol Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus
Target
-